Prescription status of edaravone and personal importation: Notice of update (English, HTML)

Prescription status of edaravone and personal importation: Notice of update: English HTML file. From Health Canada, updated Dec 2021. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2021-12-29

Organizations and the provinces/territories continue to make progress in the marketing and reimbursement of edaravone (brand name Radicava). Currently, all provinces with the exception of Prince Edward Island (PEI) have updated their drug formularies to include edaravone for public reimbursement. The territories are still in the process of establishing full coverage.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data